Press News

Press News

Press News | 11.10.2024

Print:
Title Media Publ. Date
SFEE letter to the Prime Minister about the hospital medicines Dimokratia 11/10/2024
Pharmaceutical companies’ protests over the high clawback Kathimerini 11/10/2024
Prices for basic goods and services continue to rise Kathimerini 11/10/2024
Is it true? Naftemporiki 11/10/2024
Sending sms to 2.8 million citizens for preventive examinations Ta Nea 11/10/2024
Pharmaceutical companies to the Prime Minister Ta Nea 11/10/2024

 

See here the publicity

 

Web Monitoring Report for the period 10/10 – 11/10

Title Media Publ. Date
SOS from the pharmaceutical companies for the pharmaceutical budget – There are not enough funds capital.gr 11/10/2024
SFEE: Letter of concern to Mitsotakis about the hospital clawback – Failed policy cnn.gr 10/10/2024
Adonis Georgiadis: Seeks additional funding to avoid drastic cuts to medicines – The commitments, obstacles, and background healthreport.gr 11/10/2024
End titles for the cooperation agreement between the MoH and pharmaceutical companies? The collateral loss of clawback healthstories.gr 11/10/2024
The exit of medicines and pharmaceutical companies from the country is imminent in.gr 10/10/2024
Hospital clawback: Without substantial commitments, the pharmaceutical companies meeting with Georgiadis insider.gr 11/10/2024
Pharmaceutical companies: Waiting for the clawback after the meeting with Adonis Georgiadis moneyreview.gr 11/10/2024
65.5% of businesses in Greece engaged in innovation activities moneyreview.gr 10/10/2024
Waiting for the next steps from pharmaceutical companies and the government on hospital medicines news4health.gr 11/10/2024
Serial without end the excess of pharmaceutical expenditure – Why the MoH does not provide a solution ygeiamou.gr 11/10/2024

RELATED NEWS

Skip to content
SFEE
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.